Synapticure, a virtual care company for neurodegenerative diseases, has secured $25 million in Series A funding to scale its services and expand its partnerships with health systems, payers and providers, it announced Tuesday.
Chicago-based Synapticure…
Continue Reading
Synapticure, a telemedicine company focused on people and caregivers living with neurodegenerative diseases, announced it has raised $25 million in a Series A funding round led by B Capital. New investors CVS Health Ventures, RA…
Continue Reading
What You Should Know:
– Synapticure, a virtual care company focused on neurodegenerative diseases secures $25M in a Series A funding round led by B Capital, the investment includes participation from new investors CommonSpirit Health,…
Continue Reading
The healthcare industry is slowly moving away from fee-for-service care models and toward value-based care — but contracting in these arrangements remains especially difficult for behavioral health providers, according to Taft Parsons III, chief…
Continue Reading
The MedCity Moves Podcast is back with another episode. During the episode, Senior Reporter Katie Adams explores some of the executive hires and exits occurring in the healthcare world over the past month —…
Continue Reading
In a suit filed against CVS, Walgreens, GE Healthcare and many other medical technology companies and sellers of pulse oximeters – devices that use light to measure oxygen saturation in the blood – Medtronic…
Continue Reading
New Investor Oak HC/FT Leads Round to Address Soaring Demand from Consumers and Healthcare Buyers for the Nation’s First Digestive Health Virtual Center of Excellence
Investment in Oshi Comes as Digestive Health Rises to Top…
Top News
A US Senate subcommittee report finds that UnitedHealthcare, Humana, and CVS disproportionately denied prior authorization PA requests for post-acute care in their Medicare Advantage patients, often by using AI-driven tools.
UnitedHealth’s denial rate…
Continue Reading
What You Should Know:
– CVS Health has announced the appointment of David Joyner as its new President and Chief Executive Officer, effective October 17, 2024.
– Joyner succeeds Karen Lynch, who has stepped down from…
Continue Reading
Oshi Health, a digital gastrointestinal health company, announced it scored $60 million in Series C funding in a round led by Oak HC/FT. The round also included existing investors CVS Health Ventures, Flare Capital Partners,…
Continue Reading
